MedTrace Logo

Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia

NCT01642069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2016-05-18

No results posted yet for this study

Summary

This laboratory study is looking into genes in samples from younger patients with acute megakaryoblastic leukemia (AMKL). Studying samples of blood, tissue, and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in RNA and identify biomarkers related to cancer

Conditions

  • Childhood Acute Megakaryocytic Leukemia (M7)
  • Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies

Interventions

OTHER

laboratory biomarker analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Soheil Meshinchi, MD · Children's Oncology Group

Eligibility

Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01642069 on ClinicalTrials.gov